Welcome to our dedicated page for Adtalem Global Ed news (Ticker: ATGE), a resource for investors and traders seeking the latest updates and insights on Adtalem Global Ed stock.
Adtalem Global Education Inc. (NYSE: ATGE) is a for-profit operator of colleges, universities, and professional schools with a strong focus on healthcare education. Company news frequently highlights its role as the largest or leading provider of healthcare education in the United States, as well as developments across its institutions, including Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine.
On this news page, readers can follow Adtalem’s announcements on academic and financial performance, such as quarterly and annual results, enrollment trends, and segment updates for Chamberlain, Walden, and the Medical and Veterinary segment. The company regularly issues releases on total student enrollment, revenue growth, and guidance for upcoming fiscal years, along with information about capital allocation, including share repurchase programs and debt reduction activities.
Adtalem’s news flow also covers strategic initiatives that shape its educational offerings. Examples include partnerships with health systems to fund nursing education and create employment pathways, international and domestic pathway programs into medical school, and collaborations that link medical education with data analytics and AI-focused curricula. The company has announced a strategic partnership with Google Cloud to launch an AI credentials program for healthcare professionals and has detailed initiatives to expand access to medical education through programs in regions such as India, the United Kingdom, and the United States.
Investors and observers can use this page to monitor conference call announcements, investor conference participation, and governance-related disclosures referenced in press releases. By reviewing these updates, readers gain insight into how Adtalem manages its multi-institution network, responds to healthcare workforce needs, and communicates its strategy and performance to the market.
Adtalem Global Education (NYSE: ATGE) has been named a "Stock to Study" by BetterInvesting Magazine's Editorial Advisory and Securities Review Committee for the March 2026 issue, signaling the company as worthy of further investor research. The committee highlights consolidated fundamental data—sales, earnings, pre-tax profit, return on equity—available on the Stock Selection Guide for investor review. The March 2026 issue will also feature a fundamental review of Trex Company (NYSE: TREX), identified as potentially undervalued. The committee is composed of CFA charterholders and is chaired by an editor of the magazine. Securities are presented for educational purposes only and are not endorsements; investors are advised to perform their own analysis using the Stock Selection Guide before making decisions.
Adtalem Global Education (NYSE: ATGE) will release second quarter fiscal 2026 results on Wednesday, Jan. 28, 2026 after market close.
The company will host a conference call the same day at 4:00 p.m. CT (5:00 p.m. ET) to discuss results. U.S. dial-in is +1 877-407-6184; international dial-in is +1 201-389-0877; state the prompt "Adtalem earnings call" or use conference ID 13757746. The call will be simulcast and archived on the Adtalem investor relations website with a replay available for 30 days via dial-in or the investor site.
Adtalem (NYSE: ATGE) completed a $150 million accelerated share repurchase, buying ~1.6 million shares, and its Board approved a new $750 million share repurchase authorization through December 2028. Since February 2022 the company has returned $913 million by repurchasing 17.2 million shares at an average price of $52.95, reducing shares outstanding by 30% from the Feb. 1, 2022 base. Adtalem reported 34.9 million shares outstanding as of Dec. 10, 2025 and reduced debt by $1.1 billion to $508.4 million as of Oct. 31, 2025.
The company said repurchases may occur via open market or negotiated transactions, subject to SEC rules and market conditions, and noted an Investor Day on Feb. 24, 2026.
Adtalem Global Education (NYSE: ATGE) said it will accelerate execution of its remaining $136 million under a previously authorized $150 million share repurchase program, with repurchases permitted through May 2028. The company reported Q1 enrollment +8% YoY and Q1 revenue +10.8% YoY, and reaffirmed fiscal year 2026 guidance: revenue $1,900M–$1,940M (≈6.0%–8.5% growth) and adjusted EPS $7.60–$7.90 (≈14.0%–18.5% growth). An Investor Day is scheduled for February 24, 2026.
Adtalem Global Education (NASDAQ:ATGE) is expanding pathways into medical school to help address a projected global health workforce shortfall. Key initiatives include Advanced Medical Preparation (AMP) India feeding into Ross University School of Medicine in Barbados, a guaranteed-admission route from a two-year accelerated BSc at University of Wolverhampton into American University of the Caribbean, and a U.S. partnership with ScribeAmerica offering conditional acceptances plus layered scholarship support.
The schools reported a 95% first-time residency attainment rate (2024-25). The ScribeAmerica pathway is open to ~10,000 eligible employees with no participation cap.
Adtalem Global Education (NYSE: ATGE) and Google Cloud announced a strategic partnership to launch a scalable AI credentials program for healthcare professionals, beginning in 2026. The curriculum will use Google Cloud AI technologies including Gemini and Vertex AI and aims to train students and practicing clinicians across Adtalem institutions that collectively serve over 91,000 students. The program covers clinical AI applications, ethics, patient safety, and hands-on tool experience, and will be offered as continuing education with flexible coursework for working clinicians.
Adtalem Global Education (NYSE:ATGE), America's leading healthcare educator, has scheduled its first quarter fiscal 2026 earnings release for October 30, 2025, after market close. The company will host a conference call at 4:00 p.m. CT (5:00 p.m. ET) to discuss the results.
Participants can join via phone using the toll-free number for U.S. callers or international line, or access the simulcast through Adtalem's investor relations website. A 30-day replay will be available through both phone and web platforms.
Adtalem Global Education (NYSE:ATGE), the leading healthcare educator in the United States, has announced its participation in two upcoming investor conferences in September 2025. CFO Bob Phelan will attend the 18th Annual Barrington Research Virtual Fall Investment Conference on September 16 for one-on-one investor meetings. Additionally, CEO Steve Beard and Phelan will present at the Jefferies Healthcare Services Conference in Nashville on September 30 at 1:50 p.m. CT. The Jefferies presentation will be available via live webcast and replay on Adtalem's investor relations website.
Adtalem Global Education (NYSE:ATGE) reported exceptional fiscal year 2025 results, with revenue increasing 12.9% year-over-year to $1.79 billion. The company achieved significant growth across all segments, with total enrollment up 10.2% YoY in Q4 2025.
Key highlights include adjusted EPS of $6.67 (up 33.1% YoY), adjusted EBITDA of $459.7 million (up 21.8% YoY), and record enrollments at Chamberlain (40,500+ students) and Walden (48,500+ students). The company demonstrated strong capital allocation, repurchasing $211 million of shares and maintaining a healthy net leverage ratio of 0.8x.
Looking ahead, Adtalem provided FY2026 guidance with revenue projected between $1.9-$1.94 billion and adjusted EPS of $7.60-$7.90, representing growth of 6.0-8.5% and 14.0-18.5% respectively.
FAQ
What is the current stock price of Adtalem Global Ed (ATGE)?
What is the market cap of Adtalem Global Ed (ATGE)?
